## Pharmacokinetic Distinction Between Fluticasone and Beclomethasone ### Lipophilicity and Tissue Retention **Key Point:** Fluticasone propionate is significantly more lipophilic than beclomethasone dipropionate, allowing it to partition into lung tissue and form a depot effect. This structural difference results in: - Prolonged residence time in airways (12–24 hours vs. 4–6 hours) - Longer duration of action, permitting once-daily dosing - Greater local anti-inflammatory effect per unit dose ### Comparison Table | Feature | Fluticasone Propionate | Beclomethasone Dipropionate | | --- | --- | --- | | Lipophilicity | High | Moderate | | Lung tissue retention | Prolonged (depot effect) | Shorter | | Duration of action | 12–24 hours | 4–6 hours | | Dosing frequency | Once daily | Twice daily | | Systemic bioavailability | ~1% (swallowed fraction) | ~10–20% (swallowed fraction) | | Potency (equipotent dose) | Lower absolute dose needed | Higher absolute dose needed | ### Clinical Pearl **High-Yield:** Fluticasone's superior lipophilicity is why it is preferred in maintenance therapy and allows for once-daily dosing schedules, improving compliance in asthma and COPD management [cite:KD Tripathi 8e Ch 47]. ### Why Lipophilicity Matters Lipophilic corticosteroids: 1. Dissolve readily in lung surfactant and epithelial lining fluid 2. Accumulate in airway tissue, creating a local reservoir 3. Dissociate slowly, prolonging local action 4. Reduce systemic absorption (lower bioavailability paradoxically due to lung sequestration) **Warning:** Do not confuse "higher lipophilicity" with "higher systemic side effects"—the opposite is true. Lipophilic ICS are retained locally and have lower systemic exposure.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.